Press Releases

AIDP Announces the Publication of KollaGen II-xs™ Study on reducing joint pain and improved mobility

City of Industry, CA – August 2016 – Functional ingredients leader AIDP, Inc. announces the recent publication of the 30-day clinical investigation on the safety and efficacy of KollaGen II-xs™, a unique and specialized collagen type II hydrolysate. This dietary ingredient distributed by AIDP had been shown to support joint health, including range of motion, general pain and muscle strength. It is shown to be safe and efficacious in reducing symptoms of joint discomfort, and joint and cartilage disorders. 

Download this press release Additional Download Share